Boston Scientific Corporation (BSX)
NYSE: BSX · IEX Real-Time Price · USD
68.62
0.00 (0.00%)
Mar 28, 2024, 11:00 AM EDT - Market open

Boston Scientific Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 1994
Net Income
1,570642985-1154,7001,671104347-239-119
Upgrade
Depreciation & Amortization
1,1961,1361,0931,1231,011894844815769725
Upgrade
Share-Based Compensation
233220194170157140127116107103
Upgrade
Other Operating Activities
-519-528-458297-4,032-2,395351-9654560
Upgrade
Operating Cash Flow
2,5031,5261,8701,5081,8363101,4261,1826911,269
Upgrade
Operating Cash Flow Growth
64.02%-18.40%24.01%-17.86%492.26%-78.26%20.64%71.06%-45.55%14.32%
Upgrade
Capital Expenditures
-677-506-458-277-402-302-319-347-247-259
Upgrade
Acquisitions
-1,900-1,561-1,153-134-4,441-1,448-560-408-1,734-474
Upgrade
Change in Investments
256150-1990006114
Upgrade
Other Investing Activities
1--1-1-171-131-132-266-26
Upgrade
Investing Cash Flow
-2,574-2,011-1,597-411-5,041-1,921-1,010-887-2,186-745
Upgrade
Share Issuance / Repurchase
12683604925845204948-116
Upgrade
Debt Issued / Paid
-4-1650-9992,7941,405123-1901,3850
Upgrade
Other Financing Activities
-117-466-155800121-18-33-65-157-34
Upgrade
Financing Cash Flow
5-548-952932,9731,432110-2061,276-150
Upgrade
Exchange Rate Effect
0000000-2-4-4
Upgrade
Net Cash Flow
-70-1,0421731,388-222-18853087-223370
Upgrade
Free Cash Flow
1,8261,0201,4121,2311,43481,1078354441,010
Upgrade
Free Cash Flow Growth
79.02%-27.76%14.70%-14.16%17825.00%-99.28%32.57%88.06%-56.04%10.02%
Upgrade
Free Cash Flow Margin
12.82%8.04%11.88%12.42%13.36%0.08%12.23%9.96%5.94%13.69%
Upgrade
Free Cash Flow Per Share
1.260.710.990.871.030.010.810.610.330.76
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).